SK Capital enters exclusive negotiations to acquire LISI Medical from LISI Group

SK Capital has entered exclusive negotiations to acquire LISI Group's Medical division (Lisi Medical), a MedTech CDMO producing high-precision metal components for medical devices. The transaction is expected to close in the second half of 2025, subject to regulatory approvals.

“We feel privileged to partner with LISI Group to acquire Lisi Medical, whose deep engineering heritage and cutting-edge manufacturing technologies enable it to serve as a critical solutions provider for the world's largest MedTech OEM customers.”skcapitalpartners.com

• 1 source
• skcapitalpartners.comSK Capital has entered into exclusive negotiations to acquire LISI Group’s Medical division | SK CapitalRachaelJul 9, 2025

Summarized from public sources; check the original articles before acting on it.